Find a Doctor

Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry. World J Urol. 2023 Mar 17.
View in: PubMed

Re: NIHR Global Research Health Unit on Global Surgery. Routine Sterile Glove and Instrument Change at the Time of Abdominal Wound Closure to Prevent Surgical Site Infection (ChEETAh): A Pragmatic, Cluster-randomised Trial in Seven Low-income and Middle-income Countries. Lancet 2022;400:1767-76. Eur Urol. 2023 Mar 02.
View in: PubMed

Investigating the racial gap in prostate cancer screening with prostate-specific antigen among younger men from 2012 to 2020. JNCI Cancer Spectr. 2023 03 01; 7(2).
View in: PubMed

Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap. Eur Urol Focus. 2023 Feb 24.
View in: PubMed

Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper-Tract Urothelial Carcinoma of the Ureter Compared to Radical Nephroureterectomy? Cancers (Basel). 2023 Feb 21; 15(5).
View in: PubMed

Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations. Urol Oncol. 2023 Feb 07.
View in: PubMed

Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States. Curr Oncol. 2023 02 06; 30(2):1986-1998.
View in: PubMed

Association of Variation in US County-Level Rates of Liver Surgical Resection for Colorectal Liver Metastasis With Poverty Rates in 2010. JAMA Netw Open. 2023 02 01; 6(2):e230797.
View in: PubMed

Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review. JCO Oncol Pract. 2023 Jan 12; OP2200634.
View in: PubMed

Re: Population-based Randomized Trial of Screening for Clinically Significant Prostate Cancer ProScreen: A Pilot Study. Eur Urol. 2023 Jan 04.
View in: PubMed

Long-Term Impact of Medicaid Expansion on Colorectal Cancer Screening in Its Targeted Population. Dig Dis Sci. 2023 Jan 04.
View in: PubMed

Impact of exercise on physical health status in bladder cancer patients. Can Urol Assoc J. 2023 Jan; 17(1):E8-E14.
View in: PubMed

Optimal assessment of quality of life for patients with prostate cancer. Ther Adv Med Oncol. 2022; 14:17588359221141306.
View in: PubMed

Regression modeling of time-to-event data with censoring. Nat Methods. 2022 Dec; 19(12):1513-1515.
View in: PubMed

The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis. Clin Genitourin Cancer. 2023 02; 21(1):63-68.
View in: PubMed

Clinical Applications of Machine Learning for Urolithiasis and Benign Prostatic Hyperplasia: A Systematic Review. J Endourol. 2022 Nov 10.
View in: PubMed

Understanding Hospital-Level Patterns of Nonoperative Management for Low-risk Thyroid and Kidney Cancer. JAMA Netw Open. 2022 11 01; 5(11):e2242210.
View in: PubMed

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy. PLoS One. 2022; 17(11):e0272022.
View in: PubMed

Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023 Mar; 26(1):170-179.
View in: PubMed

Radiologists' Contribution to Variation in Detecting Clinically Significant Prostate Cancer in Men With Prostate MRI. J Am Coll Radiol. 2022 12; 19(12):1312-1321.
View in: PubMed

Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy. Eur Urol Focus. 2022 Oct 11.
View in: PubMed

Top 100 Urology Influencers on Twitter: Is Social Media Influence Associated with Academic Impact? Eur Urol Focus. 2022 Oct 06.
View in: PubMed

Does the 5-item Frailty Index predict surgical complications of endoscopic surgical management for benign prostatic obstruction? An analysis of the ACS-NSQIP. World J Urol. 2022 Nov; 40(11):2649-2656.
View in: PubMed

Prostate cancer and kidney transplantation - exclusion or coexistence? BJU Int. 2022 Sep 12.
View in: PubMed

Survival analysis-time-to-event data and censoring. Nat Methods. 2022 08; 19(8):906-908.
View in: PubMed

Reforms to accelerated approval of new medicines: long overdue. Lancet. 2022 07 30; 400(10349):357-358.
View in: PubMed

A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis. Prostate. 2022 09; 82(13):1293-1303.
View in: PubMed

Trends in Launch Prices and Price Increases for New Medicines for Urological Cancers. J Urol. 2022 09; 208(3):514-516.
View in: PubMed

Association Between Alcohol Intake and Prostate Specific Antigen Screening: Results From a National Behavioral Survey. Urology. 2022 09; 167:115-120.
View in: PubMed

Nephrotoxicity of immune checkpoint inhibitor therapy: a pharmacovigilance study. Nephrol Dial Transplant. 2022 06 23; 37(7):1310-1316.
View in: PubMed

MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. Lancet Oncol. 2022 07; 23(7):910-918.
View in: PubMed

Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study. Ann Oncol. 2022 08; 33(8):836-844.
View in: PubMed

Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune response. J Intern Med. 2022 10; 292(4):654-666.
View in: PubMed

Anti-Androgen Therapy Overcomes the Time Delay in Initiation of Salvage Radiation Therapy and Rescues the Oncological Outcomes in Men with Recurrent Prostate Cancer After Radical Prostatectomy: A Post Hoc Analysis of the RTOG-9601 Trial Data. Ann Surg Oncol. 2022 Oct; 29(11):7206-7215.
View in: PubMed

Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. J Urol. 2022 09; 208(3):609-617.
View in: PubMed

Hormone Treatment of Prostate Cancer:: Evidence for Usage and Safety. Urol Clin North Am. 2022 May; 49(2):309-321.
View in: PubMed

The cost impact of disease progression to metastatic castration-sensitive prostate cancer. J Manag Care Spec Pharm. 2022 May; 28(5):544-554.
View in: PubMed

Neurocognitive impairment associated with traditional and novel androgen receptor signaling inhibitors?±?androgen deprivation therapy: a pharmacovigilance study. Prostate Cancer Prostatic Dis. 2022 Apr 18.
View in: PubMed

Digital technologies in cancer care: a review from the clinician's perspective. J Comp Eff Res. 2022 05; 11(7):533-544.
View in: PubMed

Are work relative value units correlated with operative duration of common surgical procedures? Am J Manag Care. 2022 04; 28(4):148-151.
View in: PubMed

Cost-effectiveness of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer in the UK. JAMA Netw Open. 2022 04 01; 5(4):e225740.
View in: PubMed

Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase. J Am Acad Dermatol. 2023 01; 88(1):179-181.
View in: PubMed

Association between Operative Time and Short-Term Radical Cystectomy Complications. Urol Int. 2023; 107(3):273-279.
View in: PubMed

Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade. Eur Urol. 2022 04; 81(4):323-324.
View in: PubMed

Comparison of the treatment of men with prostate cancer between the US and England: an international population-based study. Prostate Cancer Prostatic Dis. 2022 Jan 10.
View in: PubMed

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer. J Cancer Res Clin Oncol. 2022 Nov; 148(11):3091-3102.
View in: PubMed

Analysis of Surgical Volume in Military Medical Treatment Facilities and Clinical Combat Readiness of US Military Surgeons. JAMA Surg. 2022 01 01; 157(1):43-50.
View in: PubMed

Does Veteran Status Mitigate Racial Disparities in Prostate Cancer Screening? Analysis of Prostate Specific Antigen Screening Patterns in the 2018 Behavioral Risk Factor Surveillance System Data. J Urol. 2022 05; 207(5):993-1000.
View in: PubMed

How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients With Coronavirus Disease 2019 Infection? Experience in Massachusetts. Clin Infect Dis. 2021 12 06; 73(11):e4131-e4138.
View in: PubMed

ASO Visual Abstract: Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19. Ann Surg Oncol. 2021 12; 28(Suppl 3):545.
View in: PubMed

Prostate Cancer Disparities in Risk Group at Presentation and Access to Treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study With Disaggregated Ethnic Groups. JCO Oncol Pract. 2022 01; 18(1):e204-e218.
View in: PubMed

Measuring What Matters: Patient-Reported Outcome and Experience Measures for Men Undergoing Radical Prostatectomy. Eur Urol Focus. 2021 09; 7(5):913-915.
View in: PubMed

Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit. Eur Urol Open Sci. 2021 Nov; 33:1-10.
View in: PubMed

Predicting survival after radical prostatectomy: Variation of machine learning performance by race. Prostate. 2021 12; 81(16):1355-1364.
View in: PubMed

Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2021 Oct; 166:103463.
View in: PubMed

High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival. Urol Oncol. 2022 02; 40(2):62.e1-62.e11.
View in: PubMed

Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors: A Population-based Study Using SEER-Medicare Data. Am J Clin Oncol. 2021 08 01; 44(8):413-418.
View in: PubMed

Association of the hospital readmission reduction program with readmission and mortality outcomes after coronary artery bypass graft surgery. J Card Surg. 2021 Sep; 36(9):3251-3258.
View in: PubMed

Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic. Cancer Cell. 2021 08 09; 39(8):1042-1044.
View in: PubMed

Trends in Surgical Volume in the Military Health System-A Potential Threat to Mission Readiness. Mil Med. 2021 07 01; 186(7-8):646-650.
View in: PubMed

Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy. Int J Clin Oncol. 2021 Sep; 26(9):1729-1735.
View in: PubMed

Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19. Ann Surg Oncol. 2021 Dec; 28(13):8688-8696.
View in: PubMed

ASO Author Reflections: How We Convey Empathy, Address Uncertainty, and Share Serious News: Challenges to Remote Surgical Care. Ann Surg Oncol. 2021 12; 28(13):8697-8698.
View in: PubMed

Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use-Reply. JAMA Dermatol. 2021 06 01; 157(6):738.
View in: PubMed

Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation. J Natl Cancer Inst. 2021 06 01; 113(6):719-726.
View in: PubMed

Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer. Cancer Immunol Immunother. 2022 Jan; 71(1):85-95.
View in: PubMed

Racial differences in the treatment and outcomes for prostate cancer in Massachusetts. Cancer. 2021 08 01; 127(15):2714-2723.
View in: PubMed

Cardiovascular toxicities associated with abiraterone compared to enzalutamide-A pharmacovigilance study. EClinicalMedicine. 2021 Jun; 36:100887.
View in: PubMed

Limitations of using the National Cancer Database to examine the effect of policy change on stage at presentation at the population level. J Am Acad Dermatol. 2021 09; 85(3):e195-e196.
View in: PubMed

Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer. JCO Oncol Pract. 2021 05; 17(5):e654-e665.
View in: PubMed

Where Is the Value in Ambulatory Versus Inpatient Surgery? Ann Surg. 2021 05 01; 273(5):909-916.
View in: PubMed

Is Medicaid expansion associated with increases in palliative treatments for metastatic cancer? J Comp Eff Res. 2021 06; 10(9):733-741.
View in: PubMed

Comparison of comorbidity indices for prediction of morbidity and mortality after major surgical procedures. Am J Surg. 2021 Nov; 222(5):998-1004.
View in: PubMed

Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position. Cancer. 2021 07 15; 127(14):2525-2534.
View in: PubMed

Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic. Minerva Urol Nephrol. 2021 06; 73(3):404-406.
View in: PubMed

Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S. Oncologist. 2021 05; 26(5):e905-e906.
View in: PubMed

Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma. Urol Oncol. 2021 07; 39(7):436.e1-436.e10.
View in: PubMed

Temporal trends in the incidence of distant-stage bladder cancer among young individuals. Int J Urol. 2021 06; 28(6):704-705.
View in: PubMed

Reply by Authors. J Urol. 2021 05; 205(5):1274.
View in: PubMed

Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer. J Urol. 2021 07; 206(1):80-87.
View in: PubMed

Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer. Eur Urol. 2021 06; 79(6):e184-e185.
View in: PubMed

Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncol. 2021 03 01; 7(3):458-460.
View in: PubMed

A New Era in Surgical Evaluation-What Is at Stake? JAMA Surg. 2021 03 01; 156(3):e206360.
View in: PubMed

Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy. Lung. 2021 04; 199(2):199-211.
View in: PubMed

Reply to: Axel Heidenreich. Still Unanswered: The Role of Extended Pelvic Lymphadenectomy in Improving Oncological Outcomes in Prostate Cancer. Eur Urol 2021;79:605-6. Eur Urol. 2021 05; 79(5):607-608.
View in: PubMed

Is the current referral trend a threat to the Military Health System? Perioperative outcomes and costs after colorectal surgery in the Military Health System versus civilian facilities. Surgery. 2021 07; 170(1):67-74.
View in: PubMed

Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial. Urol Oncol. 2021 08; 39(8):493.e9-493.e15.
View in: PubMed

Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes? J Urol. 2021 May; 205(5):1263-1274.
View in: PubMed

Meditative and mind-body practice among patients with genitourinary malignancy. Urol Oncol. 2021 03; 39(3):192.e15-192.e20.
View in: PubMed

Value-Based Healthcare in Urology: A Collaborative Review. Eur Urol. 2021 05; 79(5):571-585.
View in: PubMed

Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride. JAMA Dermatol. 2021 01 01; 157(1):35-42.
View in: PubMed

The impact of smoking on radical cystectomy complications increases in elderly patients. Cancer. 2021 05 01; 127(9):1387-1394.
View in: PubMed

The Relationship Between Health Literacy and Nonrecommended Cancer Screening. Am J Prev Med. 2021 02; 60(2):e69-e72.
View in: PubMed

Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients. Urol Oncol. 2021 02; 39(2):130.e17-130.e24.
View in: PubMed

Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. 2021 05; 79(5):595-604.
View in: PubMed

Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers. JAMA Netw Open. 2020 12 01; 3(12):e2030072.
View in: PubMed

Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeism. Investig Clin Urol. 2021 01; 62(1):56-64.
View in: PubMed

Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States. Cancer. 2021 01 15; 127(2):249-256.
View in: PubMed

Mobile Health App for Prostate Cancer Patients on Androgen Deprivation Therapy: Qualitative Usability Study. JMIR Mhealth Uhealth. 2020 11 03; 8(11):e20224.
View in: PubMed

Clinical applications of artificial intelligence in urologic oncology. Curr Opin Urol. 2020 11; 30(6):748-753.
View in: PubMed

Response to Loughlin re: "Ambulatory-Based Bladder Outlet Procedures Offer Significant Cost Savings and Comparable 30-Day Outcomes Relative to Inpatient Surgery" by Nguyen et al. J Endourol. 2020 12; 34(12):1256-1257.
View in: PubMed

Access denied: The relationship between patient insurance status and access to high-volume hospitals. Cancer. 2021 02 15; 127(4):577-585.
View in: PubMed

Association of surgical approach and prolonged opioid prescriptions in patients undergoing major pelvic cancer procedures. BMC Surg. 2020 Oct 14; 20(1):235.
View in: PubMed

Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones. World J Urol. 2021 Jun; 39(6):2177-2182.
View in: PubMed

Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy. Curr Opin Urol. 2020 09; 30(5):701-710.
View in: PubMed

Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era? Urology. 2021 01; 147:199-204.
View in: PubMed

Accounting for Readiness-Integrating Time-Driven Activity-Based Costing (TDABC) into the Military Health System. Mil Med. 2020 08 14; 185(7-8):e930-e933.
View in: PubMed

Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making. Urology. 2020 11; 145:197-203.
View in: PubMed

Racial Disparities in Treatment for Rectal Cancer at Minority-Serving Hospitals. J Gastrointest Surg. 2021 07; 25(7):1847-1856.
View in: PubMed

Temporal Trends in the Incidence of Testicular Cancer in the United States over the Past Four Decades. Eur Urol Oncol. 2021 10; 4(5):834-836.
View in: PubMed

Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer. Urol Oncol. 2020 09; 38(9):735.e9-735.e15.
View in: PubMed

Reply by Authors. J Urol. 2020 09; 204(3):569.
View in: PubMed

Delayed blood transfusion is associated with mortality following radical cystectomy. Scand J Urol. 2020 Aug; 54(4):290-296.
View in: PubMed

Prostate cancer management costs vary by disease stage at presentation. Prostate Cancer Prostatic Dis. 2020 12; 23(4):564-566.
View in: PubMed

Prostate cancer and kidney transplantation - exclusion or co-existence? BJU Int. 2020 05; 125(5):628-629.
View in: PubMed

Lower odds of cardiac events for gonadotrophin-releasing hormone antagonists versus agonists. BJU Int. 2020 07; 126(1):9-10.
View in: PubMed

Workplace absenteeism amongst patients undergoing open vs. robotic radical prostatectomy, hysterectomy, and partial colectomy. Surg Endosc. 2021 04; 35(4):1644-1650.
View in: PubMed

Receipt of Survivorship Care Plans and Self-Reported Health Status among Patients with Genitourinary Malignancy. J Urol. 2020 Sep; 204(3):564-569.
View in: PubMed

Ambulatory-Based Bladder Outlet Procedures Offer Significant Cost Savings and Comparable 30-Day Outcomes Relative to Inpatient Procedures. J Endourol. 2020 12; 34(12):1248-1254.
View in: PubMed

Addressing the blind spot of cancer care innovation: health inequity. Ann Oncol. 2020 06; 31(6):668-670.
View in: PubMed

Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 12; 18(6):e651-e659.
View in: PubMed

Inequity in selective referral to high-volume hospitals for genitourinary malignancies. Urol Oncol. 2020 06; 38(6):582-589.
View in: PubMed

Geographic Distribution of Racial Differences in Prostate Cancer Mortality. JAMA Netw Open. 2020 03 02; 3(3):e201839.
View in: PubMed

Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer Care. Am J Clin Oncol. 2020 03; 43(3):163-167.
View in: PubMed

Using Cox regression to develop linear rank tests with zero-inflated clustered data. J R Stat Soc Ser C Appl Stat. 2020 Apr; 69(2):393-411.
View in: PubMed

All for one, one for all: is centralisation the way to go? BJU Int. 2020 02; 125(2):191-192.
View in: PubMed

Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events. J Surg Oncol. 2020 Mar; 121(3):578-583.
View in: PubMed

Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults. JAMA Netw Open. 2020 01 03; 3(1):e1919185.
View in: PubMed

Association of Affordable Care Act-related Medicaid expansion with variation in utilization of surgical services. Am J Surg. 2020 08; 220(2):441-447.
View in: PubMed

Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials. Urol Oncol. 2020 03; 38(3):78.e7-78.e13.
View in: PubMed

Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A population-based analysis. Urol Oncol. 2020 03; 38(3):74.e13-74.e20.
View in: PubMed

Facility-Level Variation in Pelvic Lymphadenectomy During Radical Prostatectomy and Effect on Overall Survival in Men with High-Risk Prostate Cancer. Ann Surg Oncol. 2020 Jun; 27(6):1929-1936.
View in: PubMed

Risk of dementia following androgen deprivation therapy for treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2020 09; 23(3):410-418.
View in: PubMed

Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis. World J Urol. 2020 Sep; 38(9):2227-2236.
View in: PubMed

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma. J Immunother Cancer. 2019 11 07; 7(1):289.
View in: PubMed

Long-term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E2805 Trial Cohort. Eur Urol. 2020 02; 77(2):277-281.
View in: PubMed

The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years. Cancer. 2020 02 01; 126(3):496-505.
View in: PubMed

Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. 2021 02; 4(1):66-72.
View in: PubMed

Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer. J Urol. 2019 11; 202(5):973-978.
View in: PubMed

United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015. Prostate Cancer Prostatic Dis. 2020 03; 23(1):179-183.
View in: PubMed

Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy. Urology. 2020 Jan; 135:44-49.
View in: PubMed

Suicide Risk Among Patients with Genitourinary Malignancies: Where Do We Stand? Eur Urol Focus. 2020 11 15; 6(6):1145-1146.
View in: PubMed

Quality Indicators for Bladder Cancer Services: A Collaborative Review. Eur Urol. 2020 07; 78(1):43-59.
View in: PubMed

Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers. J Natl Compr Canc Netw. 2019 09 01; 17(9):1049-1058.
View in: PubMed

Impact of Index Surgical Care Setting on Perioperative Outcomes and Cost Following Penile Prosthesis Surgery. J Sex Med. 2019 09; 16(9):1451-1458.
View in: PubMed

EDITORIAL COMMENT. Urology. 2019 08; 130:84-85.
View in: PubMed

Trimodal Therapy for Bladder Cancer: You Get What You Don't Pay For. JAMA Surg. 2019 08 01; 154(8):e191637.
View in: PubMed

Development and Validation of a Bedside Risk Assessment for Sustained Prescription Opioid Use After Surgery. JAMA Netw Open. 2019 07 03; 2(7):e196673.
View in: PubMed

Contemporary national trends in prostate cancer risk profile at diagnosis. Prostate Cancer Prostatic Dis. 2020 03; 23(1):81-87.
View in: PubMed

Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer. Clin Genitourin Cancer. 2019 10; 17(5):e1060-e1068.
View in: PubMed

Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. Eur Urol Focus. 2021 01; 7(1):124-131.
View in: PubMed

Reply to Michael Froehner and Christian Thomas's Letter to the Editor re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5. Eur Urol. 2019 09; 76(3):e76-e77.
View in: PubMed

Active Surveillance for Low-Risk Prostate Cancer in Black Patients. N Engl J Med. 2019 05 23; 380(21):2070-2072.
View in: PubMed

Comparison of Hospital Readmission After Total Hip and Total Knee Arthroplasty vs Spinal Surgery After Implementation of the Hospital Readmissions Reduction Program. JAMA Netw Open. 2019 05 03; 2(5):e194634.
View in: PubMed

The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals? Urol Oncol. 2019 09; 37(9):575.e9-575.e18.
View in: PubMed

Radical prostatectomy for high-risk prostate cancer | Opinion: YES. Int Braz J Urol. 2019 May-Jun; 45(3):424-427.
View in: PubMed

Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program. J Oncol Pract. 2019 06; 15(6):e547-e559.
View in: PubMed

Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis. BJU Int. 2019 07; 124(1):40-46.
View in: PubMed

Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer? Prostate Cancer Prostatic Dis. 2019 12; 22(4):593-599.
View in: PubMed

Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign. J Urol. 2019 04; 201(4):728-734.
View in: PubMed

Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals. J Urol. 2019 04; 201(4):735-741.
View in: PubMed

Testosterone replacement therapy is associated with an increased risk of urolithiasis. World J Urol. 2019 Dec; 37(12):2737-2746.
View in: PubMed

Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. J Clin Oncol. 2019 04 10; 37(11):923-931.
View in: PubMed

Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy Individuals. JNCI Cancer Spectr. 2019 Mar; 3(1):pkz003.
View in: PubMed

Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States. JAMA Netw Open. 2019 02 01; 2(2):e187633.
View in: PubMed

Multiparametric magnetic resonance imaging for prostate cancer detection: do clinical trial findings reflect real-world practice? BJU Int. 2019 02; 123(2):197-198.
View in: PubMed

Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy. Clin Genitourin Cancer. 2019 06; 17(3):e488-e493.
View in: PubMed

Reply to Amar U. Kishan, William Hall, and Daniel Spratt's Letter to the Editor re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5 Comparing Apples to Oranges: A Self-fulfilling Prophecy? Eur Urol. 2019 05; 75(5):e135-e136.
View in: PubMed

Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival? Cancer. 2019 04 15; 125(8):1319-1329.
View in: PubMed

Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Cancer. 2019 05 01; 125(9):1449-1458.
View in: PubMed

Effect of Medicaid Expansion on Colorectal Cancer Screening Rates. Dis Colon Rectum. 2019 01; 62(1):97-103.
View in: PubMed

Comparison of testis cancer-specific survival: an analysis of national cancer registry data from the USA, UK and Germany. BJU Int. 2019 03; 123(3):385-387.
View in: PubMed

Costs variations for percutaneous nephrolithotomy in the U.S. from 2003-2015: A contemporary analysis of an all-payer discharge database. Can Urol Assoc J. 2018 Dec; 12(12):407-414.
View in: PubMed

Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol. 2019 Oct; 37(10):2059-2065.
View in: PubMed

Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin Status. Ann Surg Oncol. 2019 Jan; 26(1):297-305.
View in: PubMed

Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol. 2019 04; 75(4):552-555.
View in: PubMed

Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases. Eur Urol. 2019 02; 75(2):352-353.
View in: PubMed

Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review. Eur Urol Oncol. 2019 05; 2(3):265-273.
View in: PubMed

Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy. JAMA Oncol. 2018 11 01; 4(11):1619-1620.
View in: PubMed

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer. Eur Urol. 2019 01; 75(1):35-41.
View in: PubMed

Use of Preventive Health Services Among Cancer Survivors in the U.S. Am J Prev Med. 2018 12; 55(6):830-838.
View in: PubMed

Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference? Eur Urol Oncol. 2019 07; 2(4):349-354.
View in: PubMed

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men. Eur Urol. 2019 03; 75(3):399-407.
View in: PubMed

Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol. Eur Urol Focus. 2020 01 15; 6(1):74-80.
View in: PubMed

Effect of an equal-access military health system on racial disparities in colorectal cancer screening. Cancer. 2018 09 15; 124(18):3724-3732.
View in: PubMed

Re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192-8: Comparative Survival Analyses of Radical Prostatectomy and Radiation Therapy Reveal the Importance of Adequate Follow-up Time. Eur Urol Oncol. 2019 03; 2(2):222-223.
View in: PubMed

Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomy. Urol Oncol. 2018 09; 36(9):400.e15-400.e22.
View in: PubMed

Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. Prostate Cancer Prostatic Dis. 2019 03; 22(1):125-136.
View in: PubMed

Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis. Urol Oncol. 2018 10; 36(10):469.e1-469.e11.
View in: PubMed

Contemporary perceptions of human papillomavirus and penile cancer: Perspectives from a national survey. Can Urol Assoc J. 2019 Feb; 13(2):32-37.
View in: PubMed

Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era. World J Urol. 2018 Nov; 36(11):1767-1774.
View in: PubMed

Contemporary trends in the utilisation of radical prostatectomy. BJU Int. 2018 11; 122(5):726-728.
View in: PubMed

Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. Eur J Surg Oncol. 2018 09; 44(9):1439-1445.
View in: PubMed

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA. Eur Urol Oncol. 2018 05; 1(1):83-90.
View in: PubMed

Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer. J Urol. 2018 09; 200(3):573-581.
View in: PubMed

Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce. Am J Med. 2018 05; 131(5):517-523.
View in: PubMed

Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men. BJU Int. 2018 05; 121(5):811-818.
View in: PubMed

Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol. 2018 08; 74(2):146-154.
View in: PubMed

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer. Urol Oncol. 2018 05; 36(5):238.e7-238.e17.
View in: PubMed

Reassessing the value of high-volume cancer care in the era of precision medicine. Cancer. 2018 04 01; 124(7):1319-1321.
View in: PubMed

Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis. J Urol. 2018 06; 199(6):1417-1425.
View in: PubMed

Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer. Ann Oncol. 2018 02 01; 29(2):386-391.
View in: PubMed

Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. JAMA Oncol. 2018 Feb 01; 4(2):225-229.
View in: PubMed

Adoption of robotic surgery: driven by market competition or a desire to improve patient care? Lancet Oncol. 2018 02; 19(2):e66.
View in: PubMed

Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70. Eur Urol. 2018 04; 73(4):e96-e97.
View in: PubMed

The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort. Eur Urol Focus. 2019 05; 5(3):474-481.
View in: PubMed

The new frontier of prostate biopsy: determining the role of image-guidance in moving the needle. BJU Int. 2018 01; 121(1):4-5.
View in: PubMed

Trends in Breast, Colorectal, and Cervical Cancer Incidence Following the Affordable Care Act: Implications for Cancer Screening. JAMA Oncol. 2018 Jan 01; 4(1):128-129.
View in: PubMed

Comparative effectiveness of robot-assisted vs. open radical cystectomy. Urol Oncol. 2018 03; 36(3):88.e1-88.e9.
View in: PubMed

Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade. Prostate Cancer Prostatic Dis. 2018 09; 21(3):364-372.
View in: PubMed

Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of finding the right reference standard. Cancer. 2018 03 15; 124(6):1299-1300.
View in: PubMed

Understanding the impact and challenges of secondary data analysis. Urol Oncol. 2018 04; 36(4):163-164.
View in: PubMed

Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy. Urol Oncol. 2018 02; 36(2):78.e13-78.e19.
View in: PubMed

Associations of specific postoperative complications with costs after radical cystectomy. BJU Int. 2018 03; 121(3):428-436.
View in: PubMed

Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance. Clin Genitourin Cancer. 2018 06; 16(3):226-234.
View in: PubMed

Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70. Eur Urol. 2018 04; 73(4):e100-e101.
View in: PubMed

Approach to the Patient with High-Risk Prostate Cancer. Urol Clin North Am. 2017 Nov; 44(4):635-645.
View in: PubMed

State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update. Urology. 2018 Feb; 112:56-65.
View in: PubMed

Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer. BJU Int. 2018 03; 121(3):345-347.
View in: PubMed

The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer. J Urol. 2018 02; 199(2):424-429.
View in: PubMed

The Effect of Physician Specialty Obtaining Access for Percutaneous Nephrolithotomy on Perioperative Costs and Outcomes. J Endourol. 2017 11; 31(11):1152-1156.
View in: PubMed

Immortal-time bias: a crucial yet overlooked confounder in urological research. BJU Int. 2017 10; 120(4):455.
View in: PubMed

Variation in the use of active surveillance for low-risk prostate cancer. Cancer. 2018 Jan 01; 124(1):55-64.
View in: PubMed

Secondary data sources for health services research in urologic oncology. Urol Oncol. 2018 04; 36(4):165-173.
View in: PubMed

Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis. Eur Urol. 2018 Mar; 73(3):452-461.
View in: PubMed

Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer. Clin Genitourin Cancer. 2017 Aug 24.
View in: PubMed

Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA. Eur Urol. 2018 Mar; 73(3):374-382.
View in: PubMed

Racial Disparity in Delivering Definitive Therapy for Intermediate/High-risk Localized Prostate Cancer: The Impact of Facility Features and Socioeconomic Characteristics. Eur Urol. 2018 Mar; 73(3):445-451.
View in: PubMed

Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):904-911.
View in: PubMed

Prostate Cancer Screening in Early Medicaid Expansion States. J Urol. 2018 01; 199(1):81-88.
View in: PubMed

Emergency Department Utilization in Patients With Neurogenic Bladder: Contemporary Burden and National Trends in Prevalence, Inpatient Admission, and Associated Charges, 2006-2011. Urology. 2017 Nov; 109:74-81.
View in: PubMed

Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Cancer. 2017 Nov 15; 123(22):4346-4355.
View in: PubMed

Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial. J Urol. 2018 01; 199(1):89-97.
View in: PubMed

Association between androgen deprivation therapy and anxiety among 78 000 patients with localized prostate cancer. Int J Urol. 2017 10; 24(10):743-748.
View in: PubMed

The Use of Prostate Specific Antigen Screening in Purchased versus Direct Care Settings: Data from the TRICARE® Military Database. J Urol. 2017 12; 198(6):1295-1300.
View in: PubMed

Contemporary Trends in Utilization and Perioperative Outcomes of Percutaneous Nephrolithotomy in the United States from 2003 to 2014. J Endourol. 2017 08; 31(8):742-750.
View in: PubMed

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol. 2018 02; 73(2):262-270.
View in: PubMed

Secondary data analysis: techniques for comparing interventions and their limitations. Curr Opin Urol. 2017 Jul; 27(4):354-359.
View in: PubMed

Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer. Eur Urol Focus. 2019 01; 5(1):69-76.
View in: PubMed

Reply from Authors re: Girish S. Kulkarni, Zachary Klaassen. Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? Eur Urol 2017;72:488-9: Using the National Cancer Data Base to Compare Treatment Modalities for Localized Muscle-invasive Bladder Cancer. Eur Urol. 2017 10; 72(4):489-491.
View in: PubMed

Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation. J Urol. 2017 11; 198(5):1061-1068.
View in: PubMed

Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy. Urol Oncol. 2017 09; 35(9):542.e25-542.e32.
View in: PubMed

Accountable care organizations and the use of cancer screening. Prev Med. 2017 Aug; 101:15-17.
View in: PubMed

Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses. Eur Urol Focus. 2019 01; 5(1):77-80.
View in: PubMed

Minimally invasive vs open nephrectomy in the modern era: does approach matter? World J Urol. 2017 Oct; 35(10):1557-1568.
View in: PubMed

Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer. 2017 Sep 01; 123(17):3241-3252.
View in: PubMed

Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Ann Oncol. 2017 05 01; 28(5):1098-1104.
View in: PubMed

Risk Assessment in Small Renal Masses: A Review Article. Urol Clin North Am. 2017 May; 44(2):189-202.
View in: PubMed

Do micropapillary patients benefit from chemotherapy? BJU Int. 2017 05; 119(5):656-658.
View in: PubMed

Variation in Locoregional Prostate Cancer Care and Treatment Trends at Commission on Cancer Designated Facilities: A National Cancer Data Base Analysis 2004 to 2013. Clin Genitourin Cancer. 2017 12; 15(6):e955-e968.
View in: PubMed

Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. Eur Urol. 2017 10; 72(4):483-487.
View in: PubMed

Systematic Review of the Volume-Outcome Relationship for Radical Prostatectomy. Eur Urol Focus. 2018 12; 4(6):775-789.
View in: PubMed

Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment. Eur Urol. 2017 08; 72(2):171-174.
View in: PubMed

Efficient Computation of Reduced Regression Models. Am Stat. 2017; 71(2):171-176.
View in: PubMed

Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses. Urol Oncol. 2017 07; 35(7):460.e9-460.e20.
View in: PubMed

Assessing robot-assisted laparoscopic prostatectomy. Lancet. 2017 02 25; 389(10071):799.
View in: PubMed

Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations. Eur Urol Focus. 2018 12; 4(6):1002-1004.
View in: PubMed

National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):338-343.
View in: PubMed

An Evaluation of the Timing of Surgical Complications Following Radical Cystectomy: Data From the American College of Surgeons National Surgical Quality Improvement Program. Urology. 2017 May; 103:91-98.
View in: PubMed

Editorial Comment. J Urol. 2017 05; 197(5):1206-1207.
View in: PubMed

Could lead-time bias explain the apparent benefits of early salvage radiotherapy? Nat Rev Urol. 2017 Feb 07; 14(4):193-194.
View in: PubMed

Reply to C. Buttigliero et al and B. Biswas et al. J Clin Oncol. 2017 04 10; 35(11):1266-1267.
View in: PubMed

Weighing the evidence from surgical trials. BJU Int. 2017 05; 119(5):659-660.
View in: PubMed

Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data. Curr Urol Rep. 2017 Feb; 18(2):15.
View in: PubMed

Challenging Residual Contamination of Instruments for Robotic Surgery in Japan. Infect Control Hosp Epidemiol. 2017 04; 38(4):501-502.
View in: PubMed

Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma. J Clin Oncol. 2017 Mar 10; 35(8):852-860.
View in: PubMed

Impact of Baseline Characteristics on the Survival Benefit of High-Intensity Local Treatment in Metastatic Urothelial Carcinoma of the Bladder. Eur Urol Focus. 2018 07; 4(4):568-571.
View in: PubMed

The Rise of Robotic Surgery in the New Millennium. J Urol. 2017 02; 197(2S):S213-S215.
View in: PubMed

The association of hypoalbuminemia with early perioperative outcomes - A comprehensive assessment across 16 major procedures. Am J Surg. 2017 Nov; 214(5):871-883.
View in: PubMed

Understanding the roles of randomized trials for robotic prostatectomy. Ann Transl Med. 2016 Dec; 4(23):467.
View in: PubMed

Risk of Small Bowel Obstruction After Robot-Assisted vs Open Radical Prostatectomy. J Endourol. 2016 12; 30(12):1291-1295.
View in: PubMed

Adoption of Technology and Its Impact on Nephrectomy Outcomes, a U.S. Population-Based Analysis (2008-2012). J Endourol. 2017 01; 31(1):91-99.
View in: PubMed

Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma. Eur Urol. 2017 05; 71(5):714-718.
View in: PubMed

Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer. Clin Genitourin Cancer. 2017 10; 15(5):563-569.e3.
View in: PubMed

Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis From the National Cancer Data Base. J Clin Oncol. 2016 10 10; 34(29):3529-3536.
View in: PubMed

Postoperative sepsis prediction in patients undergoing major cancer surgery. J Surg Res. 2017 03; 209:60-69.
View in: PubMed

A Reanalysis of Study of Prostate-Specific Antigen Testing Among Urologists. JAMA Intern Med. 2016 Oct 01; 176(10):1579.
View in: PubMed

Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer. Eur Urol. 2017 04; 71(4):511-514.
View in: PubMed

Does Low-value Care Affect Urologists? Eur Urol. 2017 02; 71(2):304-305.
View in: PubMed

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer. Brachytherapy. 2016 Nov - Dec; 15(6):695-700.
View in: PubMed

Treatment patterns, testicular loss and disparities in inpatient surgical management of testicular torsion in boys: a population-based study 1998-2010. BJU Int. 2016 Dec; 118(6):969-979.
View in: PubMed

National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers? Cancer. 2016 Nov 15; 122(21):3371-3377.
View in: PubMed

Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Eur Urol Focus. 2018 03; 4(2):252-259.
View in: PubMed

Determinants of cancer screening in Asian-Americans. Cancer Causes Control. 2016 08; 27(8):989-98.
View in: PubMed

Office Visits Prior to Screening Colonoscopy. JAMA. 2016 Jun 28; 315(24):2734.
View in: PubMed

Leveraging the Full Potential of Clinical Registries. Eur Urol Focus. 2019 01; 5(1):109-110.
View in: PubMed

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study. J Clin Oncol. 2016 09 20; 34(27):3267-75.
View in: PubMed

Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study. Eur Urol Focus. 2018 01; 4(1):68-74.
View in: PubMed

Association of Androgen Deprivation Therapy With Alzheimer's Disease: Unmeasured Confounders. J Clin Oncol. 2016 08 10; 34(23):2801-3.
View in: PubMed

Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. World J Urol. 2017 Feb; 35(2):199-206.
View in: PubMed

Pneumonia after Major Cancer Surgery: Temporal Trends and Patterns of Care. Can Respir J. 2016; 2016:6019416.
View in: PubMed

The influence of marital status on the use of breast, cervical, and colorectal cancer screening. Prev Med. 2016 08; 89:140-145.
View in: PubMed

The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis. Eur Urol. 2017 07; 72(1):14-19.
View in: PubMed

Surgeon and Hospital Level Variation in the Costs of Robot-Assisted Radical Prostatectomy. J Urol. 2016 Oct; 196(4):1090-5.
View in: PubMed

Re: Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2016 05; 69(5):963-4.
View in: PubMed

The Effect of Resident Involvement on Surgical Outcomes for Common Urologic Procedures: A Case Study of Uni- and Bilateral Hydrocele Repair. Urology. 2016 Aug; 94:70-6.
View in: PubMed

Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate? BJU Int. 2016 10; 118(4):633-40.
View in: PubMed

Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer. J Clin Oncol. 2016 06 01; 34(16):1905-12.
View in: PubMed

Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis. JAMA Oncol. 2016 Apr; 2(4):543-5.
View in: PubMed

Targeted Cancer Screening After Solid-Organ Transplantation. JAMA Oncol. 2016 Apr; 2(4):470.
View in: PubMed

Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy. JAMA Oncol. 2016 Apr; 2(4):500-7.
View in: PubMed

Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer. J Natl Compr Canc Netw. 2016 04; 14(4):421-8.
View in: PubMed

Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations. JAMA Intern Med. 2016 Apr; 176(4):546-7.
View in: PubMed

Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol Oncol. 2016 07; 34(7):293.e1-293.e10.
View in: PubMed

Observational Studies to Contextualize Surgical Trials. Eur Urol. 2016 08; 70(2):231-2.
View in: PubMed

New evidence from the Prostate Cancer Prevention Trial may exculpate cyclooxygenase (COX) blockers in erectile dysfunction. BJU Int. 2016 Mar; 117(3):385-6.
View in: PubMed

Data on Medicare eligibility and cancer screening utilization. Data Brief. 2016 Jun; 7:679-81.
View in: PubMed

Accurately determining patients who underwent robot-assisted surgery: limitations of administrative databases. BJU Int. 2016 09; 118(3):346-8.
View in: PubMed

Robot-assisted Versus Open Radical Prostatectomy: A Contemporary Analysis of an All-payer Discharge Database. Eur Urol. 2016 11; 70(5):837-845.
View in: PubMed

Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy. Can J Urol. 2016 Feb; 23(1):8141-50.
View in: PubMed

Relationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer. Int J Urol. 2016 Apr; 23(4):305-11.
View in: PubMed

The impact of Medicare eligibility on cancer screening behaviors. Prev Med. 2016 Apr; 85:47-52.
View in: PubMed

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer. JAMA Oncol. 2016 Jan; 2(1):85-93.
View in: PubMed

Adverse Event Rates, Timing of Complications, and the Impact of Specialty on Outcomes Following Adrenal Surgery: An Analysis of 30-Day Outcome Data From the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Urology. 2016 Apr; 90:62-8.
View in: PubMed

Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort. Urology. 2016 Apr; 90:69-74.
View in: PubMed

Causes of hospital readmissions after urologic cancer surgery. Urol Oncol. 2016 May; 34(5):236.e1-11.
View in: PubMed

Asian Americans and prostate cancer: A nationwide population-based analysis. Urol Oncol. 2016 May; 34(5):233.e7-15.
View in: PubMed

Editorial Comment. Urology. 2016 Jan; 87:86-7.
View in: PubMed

Complications After Surgery for Stress Urinary Incontinence: Untangling a Mesh of Uncertainties. JAMA Surg. 2015 Dec; 150(12):1175-6.
View in: PubMed

Racial/Ethnic Disparities in Perioperative Outcomes of Major Procedures: Results From the National Surgical Quality Improvement Program. Ann Surg. 2015 Dec; 262(6):955-64.
View in: PubMed

How can we improve surgical outcomes? BJU Int. 2015 Dec; 116(6):835-6.
View in: PubMed

Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era. J Urol. 2016 04; 195(4 Pt 1):913-8.
View in: PubMed

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations. JAMA. 2015 Nov 17; 314(19):2077-9.
View in: PubMed

Complications Following Common Inpatient Urological Procedures: Temporal Trend Analysis from 2000 to 2010. Eur Urol Focus. 2016 Apr; 2(1):3-9.
View in: PubMed

The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer. J Natl Compr Canc Netw. 2015 Nov; 13(11):1351-8.
View in: PubMed

Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012. Urol Oncol. 2016 Feb; 34(2):57.e15-22.
View in: PubMed

Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Jesse D. Sammon, Firas Abdollah, Anthony D'Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756-65. Eur Urol. 2016 06; 69(6):e129.
View in: PubMed

Rates of Kidney Transplantation From Living and Deceased Donors for Blacks and Whites in the United States, 1998 to 2011. JAMA Intern Med. 2015 Oct; 175(10):1716-8.
View in: PubMed

The Effect of Body Mass Index on Perioperative Outcomes After Major Surgery: Results from the National Surgical Quality Improvement Program (ACS-NSQIP) 2005-2011. World J Surg. 2015 Oct; 39(10):2376-85.
View in: PubMed

Occult High-risk Disease in Clinically Low-risk Prostate Cancer with =50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk? Urology. 2016 Jan; 87:125-32.
View in: PubMed

Suicide and accidental deaths among patients with non-metastatic prostate cancer. BJU Int. 2016 Aug; 118(2):286-97.
View in: PubMed

Open Versus Robotic Radical Prostatectomy in Obese Men. Curr Urol. 2015 Sep; 8(3):156-61.
View in: PubMed

Corrigendum: Inpatient hypospadias care: Trends and outcomes from the American nationwide inpatient sample. Korean J Urol. 2015 Sep; 56(9):670.
View in: PubMed

Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study. J Natl Compr Canc Netw. 2015 Sep; 13(9):1131-8.
View in: PubMed

Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancer. BJU Int. 2016 Aug; 118(2):279-85.
View in: PubMed

The Contemporary Incidence and Sequelae of Rhabdomyolysis Following Extirpative Renal Surgery: A Population Based Analysis. J Urol. 2016 Feb; 195(2):399-405.
View in: PubMed

Contemporary nationwide patterns of self-reported prostate-specific antigen screening in US veterans. Urol Oncol. 2015 Dec; 33(12):503.e7-15.
View in: PubMed

Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol. 2015 Dec; 33(12):504.e9-17.
View in: PubMed

Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9? BJU Int. 2016 Jul; 118(1):95-101.
View in: PubMed

A Surveillance, Epidemiology and End Results (SEER) database malfunction: perceptions, pitfalls and verities. BJU Int. 2016 Apr; 117(4):551-2.
View in: PubMed

Delivering better care and value in urological procedures. Can J Urol. 2015 Aug; 22(4):7857.
View in: PubMed

Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients. Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93(4):828-35.
View in: PubMed

Inpatients hypospadias care: trends and outcomes from the American nationwide inpatient sample. Korean J Urol. 2015 Aug; 56(8):594-600.
View in: PubMed

Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events. BJU Int. 2016 08; 118(2):221-9.
View in: PubMed

The influence of physician recommendation on prostate-specific antigen screening. Urol Oncol. 2015 Oct; 33(10):424.e1-7.
View in: PubMed

Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes. BJU Int. 2016 06; 117(6B):E95-E101.
View in: PubMed

Patient Characteristics and Perioperative Outcomes of Female Urethral Diverticulectomy: Analysis of a Multi-Institutional Prospective Database. Urology. 2015 Oct; 86(4):712-5.
View in: PubMed

Prevalence and risk factors of contralateral extraprostatic extension in men undergoing radical prostatectomy for unilateral disease at biopsy: A global multi-institutional experience. Can Urol Assoc J. 2015 Jul-Aug; 9(7-8):E434-8.
View in: PubMed

Factors predicting prolonged operative time for individual surgical steps of robot-assisted radical prostatectomy (RARP): A single surgeon's experience. Can Urol Assoc J. 2015 Jul-Aug; 9(7-8):E417-22.
View in: PubMed

A Comparison of 30-Day Perioperative Outcomes in Open Versus Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Carcinoma: Analysis of 896 Patients from the American College of Surgeons-National Surgical Quality Improvement Program Database. J Endourol. 2015 Sep; 29(9):1052-8.
View in: PubMed

Assessing the Contemporary Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Another Step in the Right Direction. Eur Urol. 2016 Jan; 69(1):92-3.
View in: PubMed

Association Between Older Age and Increasing Gleason Score. Clin Genitourin Cancer. 2015 Dec; 13(6):525-30.e1-3.
View in: PubMed

An evaluation of the 'weekend effect' in patients admitted with metastatic prostate cancer. BJU Int. 2015 Dec; 116(6):911-9.
View in: PubMed

Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. 2015 Dec; 68(6):949-56.
View in: PubMed

Risk of prostate cancer mortality in men with a history of prior cancer. BJU Int. 2016 06; 117(6B):E20-8.
View in: PubMed

The Effect of Resident Involvement on Perioperative Outcomes in Transurethral Urologic Surgeries. J Surg Educ. 2015 Sep-Oct; 72(5):1018-25.
View in: PubMed

Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging. Urol Oncol. 2015 Jul; 33(7):330.e19-25.
View in: PubMed

Comparison of 30-day perioperative outcomes in adults undergoing open versus minimally invasive pyeloplasty for ureteropelvic junction obstruction: analysis of 593 patients in a prospective national database. World J Urol. 2015 Dec; 33(12):2107-13.
View in: PubMed

The diminishing returns of robotic diffusion: complications after robot-assisted radical prostatectomy. BJU Int. 2016 Feb; 117(2):211-2.
View in: PubMed

Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis. BJU Int. 2015 Nov; 116(5):734-43.
View in: PubMed

Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram. BJU Int. 2015 Nov; 116(5):703-12.
View in: PubMed

Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery. World J Nephrol. 2015 May 06; 4(2):160-8.
View in: PubMed

Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they any better? Can Urol Assoc J. 2015 May-Jun; 9(5-6):207-12.
View in: PubMed

An evaluation of the timing of surgical complications following nephrectomy: data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). World J Urol. 2015 Dec; 33(12):2031-8.
View in: PubMed

Impact of smoking on perioperative outcomes after major surgery. Am J Surg. 2015 Aug; 210(2):221-229.e6.
View in: PubMed

Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials. Crit Rev Oncol Hematol. 2015 Aug; 95(2):251-63.
View in: PubMed

Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes. J Urol. 2015 Aug; 194(2):462-9.
View in: PubMed

Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology. 2015 Apr; 275(1):28-42.
View in: PubMed

The need for standardised reporting of complications. Re: Minimum 5-years follow-up of 1138 consecutive laparoscopic radical prostatectomies. BJU Int. 2015 Apr; 115(4):501-2.
View in: PubMed

Association between surgeon and hospital characteristics and lymph node counts from radical prostatectomy and pelvic lymph node dissection. Urology. 2015 Apr; 85(4):890-5.
View in: PubMed

The impact of resident involvement in male one-stage anterior urethroplasties. Urology. 2015 Apr; 85(4):937-41.
View in: PubMed

Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol. 2015 Nov; 68(5):756-65.
View in: PubMed

Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment. J Natl Cancer Inst. 2015 Jun; 107(6):djv054.
View in: PubMed

National rates and risk factors for stent failure after successful insertion in patients with obstructed, infected upper tract stones. Can Urol Assoc J. 2015 Mar-Apr; 9(3-4):E164-71.
View in: PubMed

Racial disparities in operative outcomes after major cancer surgery in the United States. World J Surg. 2015 Mar; 39(3):634-43.
View in: PubMed

Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer. J Urol. 2015 Aug; 194(2):343-9.
View in: PubMed

Incidence, admission rates, and economic burden of pediatric emergency department visits for urinary tract infection: data from the nationwide emergency department sample, 2006 to 2011. J Pediatr Urol. 2015 Oct; 11(5):246.e1-8.
View in: PubMed

Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009. Urology. 2015 Apr; 85(4):764-70.
View in: PubMed

Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients. Urology. 2015 Feb; 85(2):343-9.
View in: PubMed

Reply: To PMID 25623683. Urology. 2015 Feb; 85(2):349-50.
View in: PubMed

Effect of preoperative angina pectoris on cardiac outcomes in patients with previous myocardial infarction undergoing major noncardiac surgery (data from ACS-NSQIP). Am J Cardiol. 2015 Apr 15; 115(8):1080-4.
View in: PubMed

Who bears the greatest burden of aggressive treatment of indolent prostate cancer? Am J Med. 2015 Jun; 128(6):609-16.
View in: PubMed

Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int. 2015 May; 115(5):713-21.
View in: PubMed

Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients. BJU Int. 2015 May; 115(5):722-7.
View in: PubMed

Cost implications and complications of overtreatment of low-risk prostate cancer in the United States. J Natl Compr Canc Netw. 2015 Jan; 13(1):61-8.
View in: PubMed

Predictors of early continence following robot-assisted radical prostatectomy. Can Urol Assoc J. 2015 Jan-Feb; 9(1-2):e93-7.
View in: PubMed

Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Crit Rev Oncol Hematol. 2015 May; 94(2):228-37.
View in: PubMed

Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study. Clin Genitourin Cancer. 2015 Jun; 13(3):e123-30.
View in: PubMed

Readmissions after major urologic cancer surgery. Can J Urol. 2014 Dec; 21(6):7537-46.
View in: PubMed

Robotic and conventional open radical cystectomy lead to similar postoperative health-related quality of life. BJU Int. 2014 Dec; 114(6):793-4.
View in: PubMed

Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients. BJU Int. 2014 Dec; 114(6):824-31.
View in: PubMed

Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials. Crit Rev Oncol Hematol. 2015 Mar; 93(3):257-76.
View in: PubMed

Incidence and determinants of 1-month mortality after cancer-directed surgery. Ann Oncol. 2015 Feb; 26(2):399-406.
View in: PubMed

Editorial comment. J Urol. 2015 Feb; 193(2):505.
View in: PubMed

Diagnosis and staging of bladder cancer. Hematol Oncol Clin North Am. 2015 Apr; 29(2):205-18, vii.
View in: PubMed

Contemporary nationwide patterns of self-reported prostate-specific antigen screening. JAMA Intern Med. 2014 Nov; 174(11):1839-41.
View in: PubMed

The burden of skeletal-related events in patients with prostate cancer and bone metastasis. Urol Oncol. 2015 Jan; 33(1):17.e9-17.e18.
View in: PubMed

Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer. BJU Int. 2015 Sep; 116(3):358-65.
View in: PubMed

Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer. Eur Urol. 2015 Jul; 68(1):32-9.
View in: PubMed

Incidence and determinants of 1-month mortality after cancer-directed surgery. J Clin Oncol. 2014 Oct 20; 32(30_suppl):282.
View in: PubMed

Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population. Prostate Cancer Prostatic Dis. 2015 Mar; 18(1):13-7.
View in: PubMed

Income inequality and treatment of African American men with high-risk prostate cancer. Urol Oncol. 2015 Jan; 33(1):18.e7-18.e13.
View in: PubMed

Effect of minimally invasive surgery on the risk for surgical site infections: results from the National Surgical Quality Improvement Program (NSQIP) Database. JAMA Surg. 2014 Oct; 149(10):1039-44.
View in: PubMed

Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database. J Urol. 2015 Mar; 193(3):820-5.
View in: PubMed

Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study. Eur Urol. 2015 Jan; 67(1):3-6.
View in: PubMed

Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database. Can Urol Assoc J. 2014 Sep; 8(9-10):E681-7.
View in: PubMed

The impact of resident involvement in minimally-invasive urologic oncology procedures. Can Urol Assoc J. 2014 Sep; 8(9-10):334-40.
View in: PubMed

Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes. Can Urol Assoc J. 2014 Sep; 8(9-10):E695-701.
View in: PubMed

Perioperative aspirin: to give or not to give? BJU Int. 2014 Sep; 114(3):318-9.
View in: PubMed

Measuring the effectiveness of androgen-deprivation therapy for prostate cancer in the medicare population: adequate data are neither the same as nor the enemy of perfect data. JAMA Intern Med. 2014 Sep; 174(9):1468-9.
View in: PubMed

Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Ann Surg Oncol. 2015 Mar; 22(3):1032-42.
View in: PubMed

Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria. Int J Urol. 2015 Jan; 22(1):89-95.
View in: PubMed

Models of assessment of comparative outcomes of robot-assisted surgery: best evidence regarding the superiority or inferiority of robot-assisted radical prostatectomy. Urol Clin North Am. 2014 Nov; 41(4):597-606.
View in: PubMed

Mental health outcomes in elderly men with prostate cancer. Urol Oncol. 2014 Nov; 32(8):1333-40.
View in: PubMed

Preventable mortality after common urological surgery: failing to rescue? BJU Int. 2015 Apr; 115(4):666-74.
View in: PubMed

Predicting other-cause mortality: the minimalistic approach. Eur Urol. 2014 Dec; 66(6):1010-1.
View in: PubMed

Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma. Urol Oncol. 2014 Nov; 32(8):1259-66.
View in: PubMed

Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population-based cohort. BJU Int. 2014 Oct; 114(4):549-54.
View in: PubMed

The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study. BJU Int. 2014 Dec; 114(6b):E82-E89.
View in: PubMed

Sepsis after major cancer surgery. J Surg Res. 2015 Feb; 193(2):788-94.
View in: PubMed

Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis. BJU Int. 2014 Dec; 114(6b):E62-E69.
View in: PubMed

Chronic kidney disease and perioperative outcomes in urological oncological surgery. Int J Urol. 2014 Dec; 21(12):1245-52.
View in: PubMed

Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly. Urol Oncol. 2015 Feb; 33(2):69.e29-34.
View in: PubMed

Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J. 2014 Jul; 8(7-8):247-52.
View in: PubMed

The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act. Prostate Cancer Prostatic Dis. 2014 Sep; 17(3):273-9.
View in: PubMed

Accuracy of transrectal ultrasonography to evaluate pathologic prostate weight: correlation with various prostate size groups. Urology. 2014 Jul; 84(1):169-74.
View in: PubMed

High hospital volume reduces mortality after cystectomy. BJU Int. 2014 Jul; 114(1):5-6.
View in: PubMed

Engaging responsibly with social media: the BJUI guidelines. BJU Int. 2014 Jul; 114(1):9-11.
View in: PubMed

Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care. 2014 Jul; 52(7):579-85.
View in: PubMed

A population-based assessment of the burden of acute pancreatitis in the United States. Pancreas. 2014 Jul; 43(5):687-91.
View in: PubMed

Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology. 2014 Aug; 84(2):386-92.
View in: PubMed

Cancer-specific outcomes among young adults without health insurance. J Clin Oncol. 2014 Jul 01; 32(19):2025-30.
View in: PubMed

Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption. Urology. 2014 Jun; 83(6):1285-91.
View in: PubMed

Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life. World J Urol. 2015 Mar; 33(3):421-6.
View in: PubMed

Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer. J Geriatr Oncol. 2014 Oct 01; 5(4):352-8.
View in: PubMed

The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis. Eur J Surg Oncol. 2014 Dec; 40(12):1706-15.
View in: PubMed

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urol Oncol. 2014 Nov; 32(8):1285-91.
View in: PubMed

The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used? World J Urol. 2014 Aug; 32(4):871-80.
View in: PubMed

Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer. Clin Genitourin Cancer. 2014 Oct; 12(5):e189-95.
View in: PubMed

Refusal of curative radiation therapy and surgery among patients with cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):756-64.
View in: PubMed

Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experience. Can Urol Assoc J. 2014 May; 8(5-6):195-201.
View in: PubMed

Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study. Can Urol Assoc J. 2014 May; 8(5-6):E419-24.
View in: PubMed

Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinoma. Eur Urol. 2014 May; 65(5):1014-5.
View in: PubMed

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol. 2014 May 10; 32(14):1419-26.
View in: PubMed

Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur J Surg Oncol. 2014 Dec; 40(12):1693-9.
View in: PubMed

Weight gain on androgen deprivation therapy: which patients are at highest risk? Urology. 2014 Jun; 83(6):1316-21.
View in: PubMed

Minimally invasive vs open pyeloplasty in children: the differential effect of procedure volume on operative outcomes. Urology. 2014 Jul; 84(1):180-4.
View in: PubMed

Is there any evidence of a "July effect" in patients undergoing major cancer surgery? Can J Surg. 2014 Apr; 57(2):82-8.
View in: PubMed

Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):277-83.
View in: PubMed

Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatments. J Endourol. 2014 Jul; 28(7):784-91.
View in: PubMed

Disparities in selective referral for cancer surgeries: implications for the current healthcare delivery system. BMJ Open. 2014 Mar 23; 4(3):e003921.
View in: PubMed

Use of advanced treatment technologies among men at low risk of dying from prostate cancer. BJU Int. 2014 Aug; 114(2):166-7.
View in: PubMed

Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program. J Endourol. 2014 Jul; 28(7):831-40.
View in: PubMed

The controversy that will not go away. Eur Urol. 2015 Mar; 67(3):439-40.
View in: PubMed

Cisplatin-based chemotherapy and the risk of solid tumors in patients with testicular nonseminoma: still a matter of debate. J Clin Oncol. 2014 Apr 10; 32(11):1167.
View in: PubMed

Utilization and perioperative outcomes of robotic vaginal vault suspension compared to abdominal or vaginal approaches for pelvic organ prolapse. Can Urol Assoc J. 2014 Mar; 8(3-4):100-6.
View in: PubMed

Age-stratified distribution of metastatic sites in bladder cancer: A population-based analysis. Can Urol Assoc J. 2014 Mar-Apr; 8(3-4):E148-58.
View in: PubMed

Population-based comparative effectiveness of salvage radical prostatectomy vs cryotherapy. Urology. 2014 Mar; 83(3):653-7.
View in: PubMed

Delay in nephrectomy and cancer control outcomes in elderly patients with small renal masses. Urol Int. 2014; 92(4):455-61.
View in: PubMed

Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer. 2014 May 15; 120(10):1532-9.
View in: PubMed

Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study. Ann Oncol. 2014 May; 25(5):979-86.
View in: PubMed

Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol. 2014 Oct; 66(4):666-72.
View in: PubMed

Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample. World J Urol. 2014 Dec; 32(6):1511-21.
View in: PubMed

Correction of ureteropelvic junction obstruction in children: national trends and comparative effectiveness in operative outcomes. J Endourol. 2014 May; 28(5):592-8.
View in: PubMed

Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States. Eur Urol. 2014 Sep; 66(3):569-76.
View in: PubMed

Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. 2014 Dec; 66(6):1125-32.
View in: PubMed

The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. Eur Urol. 2014 Sep; 66(3):561-8.
View in: PubMed

Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends. J Sex Med. 2014 Apr; 11(4):1063-1070.
View in: PubMed

Editorial comment. Urology. 2014 Mar; 83(3):630-1; discussion 631.
View in: PubMed

Population-based determinants of radical prostatectomy operative time. BJU Int. 2014 May; 113(5b):E112-8.
View in: PubMed

Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urol Oncol. 2014 May; 32(4):433-40.
View in: PubMed

The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period. Eur J Surg Oncol. 2014 Sep; 40(9):1080-6.
View in: PubMed

Urological resident exposure to transurethral surgical options for BPH management in 2012-2013: A pan-Canadian survey. Can Urol Assoc J. 2014 Jan-Feb; 8(1-2):54-60.
View in: PubMed

Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy. Can Urol Assoc J. 2014 Jan-Feb; 8(1-2):E75-80.
View in: PubMed

Robotic nephrolithotomy and pyelolithotomy with utilization of the robotic ultrasound probe. Int Braz J Urol. 2014 Jan-Feb; 40(1):125-6; discussion 126.
View in: PubMed

Local tumor destruction in renal cell carcinoma--an inpatient population-based study. Urol Oncol. 2014 Jan; 32(1):54.e1-7.
View in: PubMed

Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. JAMA Surg. 2014 Jan; 149(1):43-9.
View in: PubMed

The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasis. J Urol. 2014 Jun; 191(6):1678-84.
View in: PubMed

Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol. 2014 Jul; 66(1):156-63.
View in: PubMed

A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma. Crit Rev Oncol Hematol. 2014 Apr; 90(1):49-57.
View in: PubMed

Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer. Urol Oncol. 2014 Apr; 32(3):303-8.
View in: PubMed

Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population. BJU Int. 2014 Jul; 114(1):38-45.
View in: PubMed

Effect of metastatic site on emergency department disposition in men with metastatic prostate cancer. Can J Urol. 2013 Dec; 20(6):7008-14.
View in: PubMed

Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: results from the nationwide inpatient sample. J Urol. 2014 Apr; 191(4):907-12.
View in: PubMed

180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology. 2013 Nov; 82(5):1108-13.
View in: PubMed

Distribution of metastatic sites in patients with prostate cancer: A population-based analysis. Prostate. 2014 Feb; 74(2):210-6.
View in: PubMed

Pediatric nephrectomy: incidence, indications and use of minimally invasive techniques. J Urol. 2014 Mar; 191(3):764-70.
View in: PubMed

Re: Schroeck et al.: Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia (Urology 2013;81:1177-1183). Urology. 2013 Oct; 82(4):980-1.
View in: PubMed

Predictors of admission in patients presenting to the emergency department with urinary tract infection. World J Urol. 2014 Jun; 32(3):813-9.
View in: PubMed

Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis. Eur J Surg Oncol. 2014 Jan; 40(1):103-12.
View in: PubMed

Prostate cancer: Oncological vs functional outcomes for RARP--finding a balance. Nat Rev Urol. 2013 Oct; 10(10):563-4.
View in: PubMed

Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur J Surg Oncol. 2014 Jan; 40(1):113-20.
View in: PubMed

Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care. Urol Int. 2014; 92(1):27-34.
View in: PubMed

Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014 Mar; 65(3):650-8.
View in: PubMed

A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. Urol Oncol. 2014 Jan; 32(1):46.e1-7.
View in: PubMed

Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis. BJU Int. 2014 May; 113(5):733-40.
View in: PubMed

Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort. Can Urol Assoc J. 2013 Sep-Oct; 7(9-10):E552-60.
View in: PubMed

Biliary drainage method and temporal trends in patients admitted with cholangitis: a national audit. Can J Gastroenterol. 2013 Sep; 27(9):513-8.
View in: PubMed

Percutaneous suprapubic tube bladder drainage after robot-assisted radical prostatectomy: a step-by-step guide. BJU Int. 2013 Sep; 112(5):703-5.
View in: PubMed

Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis. Int J Urol. 2014 Mar; 21(3):249-56.
View in: PubMed

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder. Br J Cancer. 2013 Sep 17; 109(6):1460-6.
View in: PubMed

Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int. 2014 Feb; 113(2):200-8.
View in: PubMed

Contemporary volume-outcome relationships for percutaneous nephrolithotomy: results from the Nationwide Inpatient Sample. J Endourol. 2013 Sep; 27(9):1107-13.
View in: PubMed

Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges. J Urol. 2014 Jan; 191(1):90-6.
View in: PubMed

Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol. 2014 Feb; 21(2):143-9.
View in: PubMed

Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology. 2013 Oct; 82(4):807-12.
View in: PubMed

FG has no added value in prediction of mortality after partial and radical nephrectomy for chromophobe renal cell carcinoma patients. Mod Pathol. 2013 Aug; 26(8):1152.
View in: PubMed

Reply to Hiten D. Patel and Mohamad E. Allaf's letter to the editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034. Eur Urol. 2013 Nov; 64(5):e107-8.
View in: PubMed

Re: Surgeon variation in patient quality of life after radical prostatectomy: A. Hartz, T. He, S. Strope, D. R. Cutler, G. Andriole and C. Dechet J Urol 2013; 189: 1295-1301. J Urol. 2013 Oct; 190(4):1441-2.
View in: PubMed

Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma. Int J Urol. 2014 Feb; 21(2):122-8.
View in: PubMed

In-hospital mortality and failure-to-rescue rates after radical cystectomy. BJU Int. 2013 Jul; 112(2):E20-7.
View in: PubMed

Understanding the way we think. BJU Int. 2013 Jul; 112(2):157.
View in: PubMed

Why I care about social media - and why you should too. BJU Int. 2013 Jul; 112(1):1-2.
View in: PubMed

National trends in hospital-acquired preventable adverse events after major cancer surgery in the USA. BMJ Open. 2013 Jun 26; 3(6).
View in: PubMed

Incidence and treatment patterns in males presenting with lower urinary tract symptoms to the emergency department in the United States. J Urol. 2013 Nov; 190(5):1798-804.
View in: PubMed

Use of surveillance imaging following treatment of small renal masses. J Urol. 2013 Nov; 190(5):1680-5.
View in: PubMed

Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time. BJU Int. 2013 Jun; 111(8):E283-9.
View in: PubMed

Sociodemographic disparities in the treatment of small renal masses. BJU Int. 2013 Jun; 111(8):E274-82.
View in: PubMed

Robot-assisted vs. laparoscopic partial nephrectomy: utilization rates and perioperative outcomes. Int Braz J Urol. 2013 May-Jun; 39(3):377-86.
View in: PubMed

A systematic review of the volume-outcome relationship for radical prostatectomy. Eur Urol. 2013 Nov; 64(5):786-98.
View in: PubMed

An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysis. BJU Int. 2013 Jun; 111(8):1184-90.
View in: PubMed

Incidence of priapism in emergency departments in the United States. J Urol. 2013 Oct; 190(4):1275-80.
View in: PubMed

Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy. BJU Int. 2013 Jun; 111(8):1208-14.
View in: PubMed

An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma. Ther Adv Urol. 2013 Apr; 5(2):121-8.
View in: PubMed

Disparities in outcomes following admission for cholangitis. PLoS One. 2013; 8(3):e59487.
View in: PubMed

Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. 2014 Jan; 65(1):235-41.
View in: PubMed

Health care-associated infections after major cancer surgery: temporal trends, patterns of care, and effect on mortality. Cancer. 2013 Jun 15; 119(12):2317-24.
View in: PubMed

Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data. BJU Int. 2014 Jan; 113(1):36-42.
View in: PubMed

Trends in surgery for upper urinary tract calculi in the USA using the Nationwide Inpatient Sample: 1999-2009. BJU Int. 2013 Jul; 112(2):224-30.
View in: PubMed

Prostate cancer screening and incidence: a question of causality. JAMA Intern Med. 2013 Mar 11; 173(5):392-3.
View in: PubMed

Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes. BJU Int. 2013 Sep; 112(5):623-37.
View in: PubMed

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int. 2013 Aug; 112(4):453-61.
View in: PubMed

Re: perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy: D. J. Parekh, J. Messer, J. Fitzgerald. B. Ercole and R. Svatek J Urol 2013; 189: 474-479. J Urol. 2013 Aug; 190(2):811-2.
View in: PubMed

Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int. 2013 Aug; 112(4):E273-80.
View in: PubMed

The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy. Urol Oncol. 2014 Jan; 32(1):29.e13-20.
View in: PubMed

Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre. BJU Int. 2013 Jun; 111(8):E331-41.
View in: PubMed

Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation. Int J Urol. 2013 Nov; 20(11):1064-71.
View in: PubMed

Trends in percutaneous nephrolithotomy use and outcomes in the United States. J Urol. 2013 Aug; 190(2):558-64.
View in: PubMed

Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy? Urol Oncol. 2014 Jan; 32(1):27.e7-13.
View in: PubMed

Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients. Mod Pathol. 2013 Aug; 26(8):1144-9.
View in: PubMed

Reply to Georgios Papadopoulos, Georgios Stathouros and Konstantinos Doumas' Letter to the editor Re: Maxine Sun, Marco Bianchi, Jens Hansen, et al. Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol 2012;62:696-703. Eur Urol. 2013 May; 63(5):e65-6.
View in: PubMed

Statistical analysis plans in observational research. JAMA. 2013 Jan 02; 309(1):32.
View in: PubMed

Complete endoscopic management of a retained bullet in the bladder. Can Urol Assoc J. 2013 Jan-Feb; 7(1-2):E143-5.
View in: PubMed

Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy. Ann Surg Oncol. 2013 Jun; 20(6):2096-102.
View in: PubMed

Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy. J Urol. 2013 Feb; 189(2):514-20.
View in: PubMed

Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. J Urol. 2013 Feb; 189(2):468-73.
View in: PubMed

Predictors of immediate continence following robot-assisted radical prostatectomy. J Endourol. 2013 Apr; 27(4):442-6.
View in: PubMed

Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists. J Urol. 2013 Jun; 189(6):2092-8.
View in: PubMed

Tablet telerounding. Urology. 2012 Dec; 80(6):1383-8.
View in: PubMed

Vattikuti Institute Prostatectomy-Technique in 2012. J Endourol. 2012 Dec; 26(12):1558-65.
View in: PubMed

Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol. 2013 Sep; 64(3):456-64.
View in: PubMed

Radiation safety knowledge and practices among urology residents and fellows: results of a nationwide survey. J Surg Educ. 2013 Mar-Apr; 70(2):224-31.
View in: PubMed

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. Br J Cancer. 2012 Nov 20; 107(11):1826-32.
View in: PubMed

Reply from authors re: Brian R. Matlaga. How do we manage infected, obstructed hydronephrosis? Eur Urol 2013;64:93-4: the infected upper urinary tract stone and obstruction: stent first where possible? Eur Urol. 2013 Jul; 64(1):95-6.
View in: PubMed

Conditional survival of patients with metastatic renal-cell carcinoma. Lancet Oncol. 2012 Nov; 13(11):e462.
View in: PubMed

Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Ann Surg Oncol. 2013 Mar; 20(3):1027-34.
View in: PubMed

Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol. 2013 Apr; 189(4):1289-94.
View in: PubMed

Off-clamp robot-assisted partial nephrectomy preserves renal function: a multi-institutional propensity score analysis. Eur Urol. 2013 Dec; 64(6):988-93.
View in: PubMed

Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis. Int J Urol. 2013 Apr; 20(4):372-80.
View in: PubMed

Effect of metabolic syndrome on pathologic features of prostate cancer. Urol Oncol. 2013 Oct; 31(7):1054-9.
View in: PubMed

Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol. 2013 Feb; 31(1):5-11.
View in: PubMed

Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States. Eur Urol. 2013 Jul; 64(1):85-92.
View in: PubMed

Proof of efficacy is not enough: contemporary management of patients with metastatic renal cell carcinoma with targeted therapy. J Clin Oncol. 2012 Nov 01; 30(31):3901; author reply 3902.
View in: PubMed

In-hospital mortality and failure to rescue after cytoreductive nephrectomy. Eur Urol. 2013 Jun; 63(6):1107-14.
View in: PubMed

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU Int. 2013 Mar; 111(3 Pt B):E30-6.
View in: PubMed

The case for partial nephrectomy: action is required. BJU Int. 2012 Oct; 110(8):1097-8.
View in: PubMed

Robotic ultrasound probe for tumor identification in robotic partial nephrectomy: Initial series and outcomes. Int J Urol. 2013 Feb; 20(2):172-6.
View in: PubMed

Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy. Eur J Surg Oncol. 2012 Nov; 38(11):1082-8.
View in: PubMed

Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study. Can Urol Assoc J. 2012 Aug; 6(4):245-50.
View in: PubMed

The effect of gender on nephrectomy perioperative outcomes: a national survey. Can J Urol. 2012 Aug; 19(4):6337-44.
View in: PubMed

Editorial comment to robot-assisted or pure laparoscopic nerve-sparing radical prostatectomy: what is the optimal procedure for the surgical margins? A single center experience. Int J Urol. 2012 Dec; 19(12):1082.
View in: PubMed

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol. 2012 Dec; 30(6):807-14.
View in: PubMed

National trends and disparities in the use of minimally invasive adult pyeloplasty. J Urol. 2012 Sep; 188(3):913-8.
View in: PubMed

Adoption of robotic surgery: an analogy from urologic oncology. J Clin Oncol. 2012 Aug 10; 30(23):2931-2; author reply 2932-3.
View in: PubMed

Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol. 2013 Feb; 63(2):371-8.
View in: PubMed

Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834. J Urol. 2012 Aug; 188(2):677-8.
View in: PubMed

Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer? J Sex Med. 2012 Nov; 9(11):2961-9.
View in: PubMed

Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged =75 years with multiple comorbidities. BJU Int. 2013 Jan; 111(1):67-73.
View in: PubMed

Causality in administrative datasets. J Crohns Colitis. 2012 Sep; 6(8):867; author reply 868.
View in: PubMed

Are medicare-based findings applicable to all prostatectomy patients? J Clin Oncol. 2012 Jun 20; 30(18):2286-7; author reply 2287.
View in: PubMed

Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014 Jan; 65(1):210-7.
View in: PubMed

A review of integrated staging systems for renal cell carcinoma. Eur Urol. 2012 Aug; 62(2):303-14.
View in: PubMed

Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: a detailed assessment of margin extent and location. Urol Oncol. 2013 Nov; 31(8):1470-6.
View in: PubMed

Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study. Eur J Surg Oncol. 2012 Jul; 38(7):624-9.
View in: PubMed

Re: A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy: P. Pillai, I. McEleavy, M. Gaughan, C. Snowden, I. Nesbitt, G. Durkan, M. Johnson, J. Cosgrove and A. Thorpe J Urol 2011; 186: 2201-2206. J Urol. 2012 Jun; 187(6):2278; author reply 2279.
View in: PubMed

Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy. Urology. 2012 Apr; 79(4):796-803.
View in: PubMed

Variations in the quality of care at radical prostatectomy. Ther Adv Urol. 2012 Apr; 4(2):61-75.
View in: PubMed

Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol. 2012 Oct; 62(4):696-703.
View in: PubMed

Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU Int. 2012 Nov; 110(9):1301-9.
View in: PubMed

Robot-assisted radical prostatectomy: ready to be counted? Eur Urol. 2012 Jul; 62(1):16-8; discussion 18-9.
View in: PubMed

Re: improved prediction of long-term, other cause mortality in men with prostate cancer: T. J. Daskivich, K. Chamie, L. Kwan, J. Labo, A. Dash, S. Greenfield and M. S. Litwin, J Urol 2011; 186: 1868-1873. J Urol. 2012 May; 187(5):1931.
View in: PubMed

Leapfrog volume thresholds and perioperative complications after radical prostatectomy. Cancer. 2012 Oct 15; 118(20):4991-8.
View in: PubMed

Discharge patterns after radical cystectomy: contemporary trends in the United States. J Urol. 2012 Apr; 187(4):1206-9.
View in: PubMed

Treatment management of small renal masses in the 21st century: a paradigm shift. Ann Surg Oncol. 2012 Jul; 19(7):2380-7.
View in: PubMed

Robot-assisted urological surgery: Current status and future perspectives. Arab J Urol. 2012 Mar; 10(1):17-22.
View in: PubMed

Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis. BJU Int. 2012 Sep; 110(6 Pt B):E183-90.
View in: PubMed

Venous thromboembolism after radical prostatectomy: the effect of surgical caseload. BJU Int. 2012 Sep; 110(6):828-33.
View in: PubMed

Disparities in access to care at high-volume institutions for uro-oncologic procedures. Cancer. 2012 Sep 15; 118(18):4421-6.
View in: PubMed

The phantom menace of prostate cancer screening. BJU Int. 2012 Feb; 109(3):324-6.
View in: PubMed

Venous thromboembolism in colorectal surgery: how much does laparoscopy impart an advantage? Arch Surg. 2012 Feb; 147(2):199.
View in: PubMed

Blood transfusions in radical prostatectomy: a contemporary population-based analysis. Urology. 2012 Feb; 79(2):332-8.
View in: PubMed

Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: time reduction and cost benefit. BJU Int. 2012 May; 109(10):1526-32.
View in: PubMed

Is robotic surgery cost-effective: yes. Curr Opin Urol. 2012 Jan; 22(1):61-5.
View in: PubMed

Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol. 2012 Apr; 61(4):679-85.
View in: PubMed

Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. Eur Urol. 2012 Apr; 61(4):715-21.
View in: PubMed

Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. Eur J Cancer. 2012 Jul; 48(10):1503-11.
View in: PubMed

Long-term follow-up of patients undergoing percutaneous suprapubic tube drainage after robot-assisted radical prostatectomy (RARP). BJU Int. 2012 Aug; 110(4):580-5.
View in: PubMed

Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy. J Urol. 2012 Feb; 187(2):405-10.
View in: PubMed

The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy. Int Urol Nephrol. 2012 Jun; 44(3):799-806.
View in: PubMed

A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol. 2012 Apr; 61(4):725-31.
View in: PubMed

Discharge patterns after radical prostatectomy in the United States of America. Urol Oncol. 2013 Oct; 31(7):1022-32.
View in: PubMed

Training and outcome monitoring in robotic urologic surgery. Nat Rev Urol. 2011 Nov 08; 9(1):17-22.
View in: PubMed

Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort. BJU Int. 2012 Jul; 110(2 Pt 2):E21-7.
View in: PubMed

Radical prostatectomy at academic versus nonacademic institutions: a population based analysis. J Urol. 2011 Nov; 186(5):1849-54.
View in: PubMed

Editorial comment. J Urol. 2011 Nov; 186(5):1777-8.
View in: PubMed

Does partial nephrectomy at an academic institution result in better outcomes? World J Urol. 2012 Aug; 30(4):505-10.
View in: PubMed

Open radical prostatectomy in the elderly: a case for concern? BJU Int. 2012 May; 109(9):1335-40.
View in: PubMed

Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States. Cancer. 2012 Apr 01; 118(7):1894-900.
View in: PubMed

The effect of insurance status on outcomes after partial nephrectomy. Int Urol Nephrol. 2012 Apr; 44(2):343-51.
View in: PubMed

Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status. Urology. 2011 Nov; 78(5):977-84.
View in: PubMed

Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer. 2012 Apr 01; 118(7):1803-10.
View in: PubMed

A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis. Eur Urol. 2011 Dec; 60(6):1152-9.
View in: PubMed

Surgery for high-risk localized prostate cancer. Ther Adv Urol. 2011 Aug; 3(4):173-82.
View in: PubMed

Anastomosis during robot-assisted radical prostatectomy: randomized controlled trial comparing barbed and standard monofilament suture. Urology. 2011 Sep; 78(3):572-9.
View in: PubMed

A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomy. Eur Urol. 2011 Sep; 60(3):564-71.
View in: PubMed

Novel method of knotless vesicourethral anastomosis during robot-assisted radical prostatectomy: feasibility study and early outcomes in 30 patients using the interlocked barbed unidirectional V-LOC180 suture. Can Urol Assoc J. 2011 Jun; 5(3):188-94.
View in: PubMed

Robotic radical prostatectomy: a critical analysis of surgical quality. Curr Opin Urol. 2011 May; 21(3):195-9.
View in: PubMed

Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol. 2011 May; 59(5):684-98.
View in: PubMed

The current management of small renal masses. Curr Opin Support Palliat Care. 2009 Sep; 3(3):180-5.
View in: PubMed

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. Int J Cancer. 2008 Jul 15; 123(2):395-400.
View in: PubMed

Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma. J Trauma. 2008 Jun; 64(6):1451-8.
View in: PubMed

Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int. 2007 Dec; 100(6):1254-8.
View in: PubMed

Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int. 2007 Oct; 100(4):802-8.
View in: PubMed

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer. 2007 Sep 15; 110(6):1241-7.
View in: PubMed

Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms. J Urol. 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7.
View in: PubMed

Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007 Apr 10; 25(11):1316-22.
View in: PubMed

Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol. 2007 Nov; 52(5):1428-36.
View in: PubMed

ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival. Eur J Cancer. 2007 Apr; 43(6):1023-9.
View in: PubMed

Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer. 2007 Mar 01; 109(5):868-74.
View in: PubMed

Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol. 2007 Oct; 52(4):1140-5.
View in: PubMed

Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8. Eur Urol. 2007 Jun; 51(6):1478-80.
View in: PubMed

Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol. 2007 Jun; 51(6):1616-24.
View in: PubMed

Sunitinib relieves renal cell carcinoma spinal cord compression. Eur Urol. 2007 Jun; 51(6):1741-3.
View in: PubMed

Polymorphism, shared functions and convergent evolution of genes with sequences coding for polyalanine domains. Hum Mol Genet. 2003 Nov 15; 12(22):2967-79.
View in: PubMed